DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 171 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $11,265,000 | -18.4% | 307,703 | 0.0% | 0.37% | -22.9% |
| Q1 2021 | $13,797,000 | +294.0% | 307,703 | +401.4% | 0.48% | +286.2% |
| Q4 2020 | $3,502,000 | +11.2% | 61,370 | 0.0% | 0.12% | +4.2% |
| Q3 2020 | $3,148,000 | -14.1% | 61,370 | 0.0% | 0.12% | -15.1% |
| Q2 2020 | $3,665,000 | +45.0% | 61,370 | 0.0% | 0.14% | +21.9% |
| Q1 2020 | $2,527,000 | -33.8% | 61,370 | 0.0% | 0.11% | -20.8% |
| Q4 2019 | $3,820,000 | – | 61,370 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $72,236,000 | 20.73% |
| SV Health Investors, LLC | 449,951 | $26,871,000 | 18.64% |
| Redmile Group, LLC | 4,978,941 | $297,342,000 | 5.49% |
| Sunesis Advisors, LLC | 96,299 | $5,751,000 | 5.29% |
| Eversept Partners, LP | 418,652 | $25,001,897 | 3.43% |
| Opaleye Management Inc. | 222,000 | $13,081,000 | 2.64% |
| Avoro Capital Advisors LLC | 1,860,000 | $111,079,000 | 2.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 282,965 | $16,899,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 224,359 | $13,399,000 | 1.23% |
| Artal Group S.A. | 650,000 | $38,818,000 | 1.09% |